Home
>
National Drug Code (NDC)
>
RETROVIR
RETROVIR - 0173-0113-18 - (zidovudine)
Drug Information of RETROVIR
| Product NDC: | 0173-0113 |
| Proprietary Name: | RETROVIR |
| Non Proprietary Name: | zidovudine |
| Active Ingredient(s): | 50 mg/5mL & nbsp; zidovudine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SYRUP |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of RETROVIR
| Product NDC: | 0173-0113 |
| Labeler Name: | GlaxoSmithKline LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA019910 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19891010 |
Package Information of RETROVIR
| Package NDC: | 0173-0113-18 |
| Package Description: | 240 mL in 1 BOTTLE (0173-0113-18) |
NDC Information of RETROVIR
| NDC Code | 0173-0113-18 |
| Proprietary Name | RETROVIR |
| Package Description | 240 mL in 1 BOTTLE (0173-0113-18) |
| Product NDC | 0173-0113 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | zidovudine |
| Dosage Form Name | SYRUP |
| Route Name | ORAL |
| Start Marketing Date | 19891010 |
| Marketing Category Name | NDA |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | ZIDOVUDINE |
| Strength Number | 50 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
